Navigation Links
Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
Date:10/24/2013

rded the very prestigious Commander in the Order of Leopold, an extremely high honor of Belgium, for meritorious service of immense benefit to the country.

"We are honored to have Dr. Carson and Dr. Vermorken join our medical advisory board, and we believe they both will play a vital role in helping Vaccinogen bring OncoVAX to the millions of patients afflicted with cancer," Dr. Hanna explained.  "Their significant knowledge and experience will be invaluable as we work towards our goal of commercializing a therapeutic process where a patient's own tumor can be used to train his or her own immune system to fight all of the genetically diverse tumor targets in residual and recurring tumor cells."

About Vaccinogen, Inc.

Vaccinogen, Inc. is a cancer vaccine company that is clinically testing its OncoVAX® treatment which is designed to prevent the recurrence of colon cancer and potentially other solid tumors. It is a patented process that circumvents the extreme diversity of tumor cells by leveraging a patient's own live tumor cells to launch a broad immune response against colon cancer. The Company believes that OncoVAX, at an optimum dose and regimen, is the first colon cancer vaccine to demonstrate effectiveness in both preventing cancer recurrence after surgical resection of the primary tumor and addressing the diversity of cancer cells.  OncoVAX has completed five clinical studies, including a Phase III trial with the optimum dose and regimen.  The Company expects to begin a pivotal Phase IIIb trial under an FDA Special Protocol Assessment (SPA) classification in the fourth quarter of 2013. The SEC completed its review of Vaccinogen's Form 10 registration statement on October 16, 2013.  The Company's shares trade on the OTC.QB under the symbol "VGEN".  More information is available at www.vaccinogeninc.com

Forward Looking Statement
'/>"/>

SOURCE Vaccinogen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
3. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
4. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
5. Codexis Names Wes Bolsen VP and Chief Marketing Officer
6. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
7. Fitzsimons Redevelopment Authority Names New President & CEO
8. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
9. Laureate Biopharma Names James D. Utterback to Board of Directors
10. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
11. Hospira Names John B. Elliot Senior Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 EPFL and the University of  ... of John P. Donoghue . The American neuroscientist ... . The new Wyss Center for ... Geneva , has named as its director ... P. Donoghue , founder of Brown University,s Institute for ...
(Date:7/10/2014)... July 10, 2014 Product and ... very low abundance and are often “lost in ... time-consuming. , Join presenters Dr. Rowel Tobias, Senior ... John Anders, Head of Quality at Nanotherapeutics, Inc., ... that can speed detection and quantitation while achieving ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., the ... relaunch of his highly informative blog, now named Stem Cells ... are Stem Cells ?” Dr. Harman’s purpose for blogging ... basics of stem cell therapy so that pet owners can ... when considering regenerative medicine. , A veterinarian by trade, Dr. ...
(Date:7/10/2014)... PETERSBURG, Russia , July 10, 2014 ... Russian Federation Dmitry Medvedev , presented ... biopharmaceutical company BIOCAD . The Company is developing ... scope of MabNext project BIOCAD develops a number of ... cancer and autoimmune diseases. The ceremony took place at ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2
... Nanometre-scale gold particles are currently intensively investigated for ... carriers and molecular electronics. The particles are prepared ... reactive gold cores can be stabilised with various ... by using organothiolate ligands that have a strong ...
... Cord Blood Corporation (NYSE: CO ) ("CCBC" or ... testing, hematopoietic stem cell processing, and stem cell storage services, ... first nine months of fiscal year 2011 ended December 31, ... of Fiscal 2011 Highlights Revenue ...
... 2011 Epeius Biotechnologies ( www.epeiusbiotech.com ) announced today that ... Company,s lead anti-cancer agent, Rexin-G , the first, and ... to seek out and destroy metastatic cancer. According to Dr. ... in terms of clinical development, is that the Rexin-G product, ...
Cached Biology Technology:Fingerprints of a gold cluster revealed 2China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 2China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 3China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 4China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 5China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 6China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 7China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 8China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 9China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 10China Cord Blood Corporation Reports Third Quarter and First Nine Months of Fiscal 2011 Financial Results 11Epeius Biotechnologies' REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA 2
(Date:7/11/2014)... Chicago is creating a new professorship in tissue ... Institute for Molecular Engineering and the Marine Biological ... the Millicent and Eugene Bell Foundation., The Eugene ... the Institute for Molecular Engineering. That endowed chair ... the MBL,s Eugene Bell Center for Regenerative Biology ...
(Date:7/11/2014)... Cell scientists have set a "mouse TRAP" to capture ... a recent study published in the Journal of ... a technique called TRAP to extract cellular and genetic ... by scientists at the Rockefeller Institute for Medical Research ... the protein-making machinery, or ribosomes, of the cell type ...
(Date:7/11/2014)... researchers from The Chinese University of Hong Kong, BGI ... soybean linked to salt tolerance, with implication for improving ... study published online in Nature Communications provides ... crop improvement. , Soybean is an important crop for ... soybeans have less genetic diversities than their wild counterparts. ...
Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2BGI reports a novel gene for salt tolerance found in wild soybean 2
... This release is available in German . ... hibernating common pipistrelle bats under harsh conditions of snow cover. ... Max Planck Institute for Ornithology in Seewiesen and their colleagues ... birds alternative feed, they ate it and showed little or ...
... parasites from spreading throughout the body has seen Dr ... named a Young Tall Poppy by the Australian Institute ... postdoctoral fellow in the institute,s Infection and Immunity division, ... parasite,s movement. "Malaria parasites use a unique ...
... Park of Cornell University, who receives funding for basic ... (AFOSR), is investigating carbon nanostructures that may some day ... for the Air Force. "Devices that are required ... different from commercial ones in the sense that they ...
Cached Biology News:Great tits eat bats in times of need 2Malaria research wins Jake Baum a Young Tall Poppy award 2AFOSR's basic research may lead to revolutionary new devices 2
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... demand is causing shortages in your laboratory ... can cause unwanted distractions, problems and delays. ... for your hard work and endeavour! Bring ... it up,and market it internationally. We work ...
... shortages in your laboratory or fellow researchers want ... problems and delays. • ... Bring us your idea and let us build ... under ISO 9001 quality assurance in design, development, ...
... (rat) - Diluted Antiserum for RIA, Host: ... U-23 (rat) Immunology Products, Host: Rabbit ... our corresponding peptide and 1 ... Neuromedin U-23 (rat) (H-9295) and ([ 1 ...
Biology Products: